{
  "id": 12745602,
  "title": "Grail chief growth officer Andrew Partridge sells $1.15m in stock",
  "url": "https://urgent.news/2026/10/07/grail-chief-growth-officer-andrew-partridge-sells-1-15m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-07T23:46:16.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/grail-chief-growth-officer-andrew-partridge-sells-115m-in-stock-93CH-4937727"
  },
  "original_language": "en",
  "account": "Chief Growth Officer of GRAIL, Andrew Partridge, divested a block of 7,873 shares on October 5, 2026, through an automatic 'sell-to-cover' transaction. This sale was worth $1,152,528 and executed at a weighted average price of $146.39 per share. The shares were part of the vesting process of awards, intended to satisfy tax obligations. The current stock price of $132.90 is below the transaction price, despite GRAIL's impressive 170% return over the past six months.\n\nPost the sale, Partridge holds 155,865 shares of GRAIL common stock. According to InvestingPro analysis, GRAIL stock may be overvalued, showing high volatility with a beta of 2.84. Investors can access GRAIL's Pro Research Report for more in-depth information.\n\nRecent news surrounding GRAIL includes the FDA advisory committee's unanimous vote to approve the safety and effectiveness of the Galleri multi-cancer early detection test. Canaccord Genuity raised its price target to $150 with a Buy rating, while Mizuho increased its target to $100 with a Neutral rating. RBC Capital has initiated coverage with a Sector Perform rating and a price target of $84, citing challenges related to reimbursement and adoption. Despite these concerns, the FDA staff showed no significant issues regarding accuracy and safety. These developments suggest a positive outlook for GRAIL's Galleri test pending further regulatory approvals.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Grail CFO Aaron Freidin sells $3.46m in company stock",
        "url": "https://urgent.news/2026/10/07/grail-cfo-aaron-freidin-sells-3-46m-in-company-stock",
        "published": "2026-10-07T23:46:06.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}